Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary

J. S. Bajaj, R. T. Frederick, N. M. Bass, Marwan Ghabril, K. Coyne, M. K. Margolis, M. Santoro, D. F. Coakley, M. Mokhtarani, M. Jurek, B. F. Scharschmidt

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Clinical management and clinical trials of patients with overt hepatic encephalopathy (OHE) are compromised by lack of standardized and reproducible tools for its clinical diagnosis or for caregiver (CG) identification of OHE manifestations which merit medical evaluation. Using an iterative Delphi method, Steering Committee and international hepatologist panel, the West Haven (WH) scale was modified to develop and operationalize a clinician tool for OHE identification and grading (HE Grading Instrument, HEGI™). Major diagnostic criteria included disorientation to time, place, and person, asterixis, lethargy, and coma. Minimum HEGI requirements for OHE diagnosis included: (1) disorientation, or (2) presence of both lethargy and asterixis, or (3) coma. Inter- and intra-rater HEGI reproducibility were 97 % and 98 %, respectively. When applied to a phase II clinical trial population of 178 patients with 388 OHE episodes, HEGI demonstrated excellent concordance with investigator judgement. Additionally, a multi-stage study was conducted to develop a daily CG e-diary, based on OHE manifestations recognizable by CG including speech difficulties, unusual behavior, forgetfulness, confusion, disorientation and level of consciousness. The e-diary was designed for use on smart phone, laptop or desktop, utilized branching logic and skip patterns, incorporated automatic daily completion reminders and real time alerts to clinical sites to facilitate daily standardized CG input and was found to be user friendly and understandable. The HEGI and e-diary, which were developed using methodology accepted by regulatory authorities, are designed to facilitate the design and interpretation of clinical trials for OHE and improve outcomes for OHE patients in clinical practice.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalMetabolic Brain Disease
DOIs
StateAccepted/In press - Jun 9 2016

Fingerprint

Hepatic Encephalopathy
Caregivers
Confusion
Lethargy
Dyskinesias
Coma
Clinical Trials
Iterative methods
Phase II Clinical Trials
Consciousness
Research Personnel

Keywords

  • Altered mental status
  • Chronic liver disease
  • Cirrhosis
  • Clinical trial
  • Liver failure

ASJC Scopus subject areas

  • Clinical Neurology
  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Bajaj, J. S., Frederick, R. T., Bass, N. M., Ghabril, M., Coyne, K., Margolis, M. K., ... Scharschmidt, B. F. (Accepted/In press). Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary. Metabolic Brain Disease, 1-13. https://doi.org/10.1007/s11011-016-9851-9

Overt hepatic encephalopathy : development of a novel clinician reported outcome tool and electronic caregiver diary. / Bajaj, J. S.; Frederick, R. T.; Bass, N. M.; Ghabril, Marwan; Coyne, K.; Margolis, M. K.; Santoro, M.; Coakley, D. F.; Mokhtarani, M.; Jurek, M.; Scharschmidt, B. F.

In: Metabolic Brain Disease, 09.06.2016, p. 1-13.

Research output: Contribution to journalArticle

Bajaj, JS, Frederick, RT, Bass, NM, Ghabril, M, Coyne, K, Margolis, MK, Santoro, M, Coakley, DF, Mokhtarani, M, Jurek, M & Scharschmidt, BF 2016, 'Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary', Metabolic Brain Disease, pp. 1-13. https://doi.org/10.1007/s11011-016-9851-9
Bajaj, J. S. ; Frederick, R. T. ; Bass, N. M. ; Ghabril, Marwan ; Coyne, K. ; Margolis, M. K. ; Santoro, M. ; Coakley, D. F. ; Mokhtarani, M. ; Jurek, M. ; Scharschmidt, B. F. / Overt hepatic encephalopathy : development of a novel clinician reported outcome tool and electronic caregiver diary. In: Metabolic Brain Disease. 2016 ; pp. 1-13.
@article{842f8247b136410d977bb9c8a11625a4,
title = "Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary",
abstract = "Clinical management and clinical trials of patients with overt hepatic encephalopathy (OHE) are compromised by lack of standardized and reproducible tools for its clinical diagnosis or for caregiver (CG) identification of OHE manifestations which merit medical evaluation. Using an iterative Delphi method, Steering Committee and international hepatologist panel, the West Haven (WH) scale was modified to develop and operationalize a clinician tool for OHE identification and grading (HE Grading Instrument, HEGI™). Major diagnostic criteria included disorientation to time, place, and person, asterixis, lethargy, and coma. Minimum HEGI requirements for OHE diagnosis included: (1) disorientation, or (2) presence of both lethargy and asterixis, or (3) coma. Inter- and intra-rater HEGI reproducibility were 97 {\%} and 98 {\%}, respectively. When applied to a phase II clinical trial population of 178 patients with 388 OHE episodes, HEGI demonstrated excellent concordance with investigator judgement. Additionally, a multi-stage study was conducted to develop a daily CG e-diary, based on OHE manifestations recognizable by CG including speech difficulties, unusual behavior, forgetfulness, confusion, disorientation and level of consciousness. The e-diary was designed for use on smart phone, laptop or desktop, utilized branching logic and skip patterns, incorporated automatic daily completion reminders and real time alerts to clinical sites to facilitate daily standardized CG input and was found to be user friendly and understandable. The HEGI and e-diary, which were developed using methodology accepted by regulatory authorities, are designed to facilitate the design and interpretation of clinical trials for OHE and improve outcomes for OHE patients in clinical practice.",
keywords = "Altered mental status, Chronic liver disease, Cirrhosis, Clinical trial, Liver failure",
author = "Bajaj, {J. S.} and Frederick, {R. T.} and Bass, {N. M.} and Marwan Ghabril and K. Coyne and Margolis, {M. K.} and M. Santoro and Coakley, {D. F.} and M. Mokhtarani and M. Jurek and Scharschmidt, {B. F.}",
year = "2016",
month = "6",
day = "9",
doi = "10.1007/s11011-016-9851-9",
language = "English (US)",
pages = "1--13",
journal = "Metabolic Brain Disease",
issn = "0885-7490",
publisher = "Springer New York",

}

TY - JOUR

T1 - Overt hepatic encephalopathy

T2 - development of a novel clinician reported outcome tool and electronic caregiver diary

AU - Bajaj, J. S.

AU - Frederick, R. T.

AU - Bass, N. M.

AU - Ghabril, Marwan

AU - Coyne, K.

AU - Margolis, M. K.

AU - Santoro, M.

AU - Coakley, D. F.

AU - Mokhtarani, M.

AU - Jurek, M.

AU - Scharschmidt, B. F.

PY - 2016/6/9

Y1 - 2016/6/9

N2 - Clinical management and clinical trials of patients with overt hepatic encephalopathy (OHE) are compromised by lack of standardized and reproducible tools for its clinical diagnosis or for caregiver (CG) identification of OHE manifestations which merit medical evaluation. Using an iterative Delphi method, Steering Committee and international hepatologist panel, the West Haven (WH) scale was modified to develop and operationalize a clinician tool for OHE identification and grading (HE Grading Instrument, HEGI™). Major diagnostic criteria included disorientation to time, place, and person, asterixis, lethargy, and coma. Minimum HEGI requirements for OHE diagnosis included: (1) disorientation, or (2) presence of both lethargy and asterixis, or (3) coma. Inter- and intra-rater HEGI reproducibility were 97 % and 98 %, respectively. When applied to a phase II clinical trial population of 178 patients with 388 OHE episodes, HEGI demonstrated excellent concordance with investigator judgement. Additionally, a multi-stage study was conducted to develop a daily CG e-diary, based on OHE manifestations recognizable by CG including speech difficulties, unusual behavior, forgetfulness, confusion, disorientation and level of consciousness. The e-diary was designed for use on smart phone, laptop or desktop, utilized branching logic and skip patterns, incorporated automatic daily completion reminders and real time alerts to clinical sites to facilitate daily standardized CG input and was found to be user friendly and understandable. The HEGI and e-diary, which were developed using methodology accepted by regulatory authorities, are designed to facilitate the design and interpretation of clinical trials for OHE and improve outcomes for OHE patients in clinical practice.

AB - Clinical management and clinical trials of patients with overt hepatic encephalopathy (OHE) are compromised by lack of standardized and reproducible tools for its clinical diagnosis or for caregiver (CG) identification of OHE manifestations which merit medical evaluation. Using an iterative Delphi method, Steering Committee and international hepatologist panel, the West Haven (WH) scale was modified to develop and operationalize a clinician tool for OHE identification and grading (HE Grading Instrument, HEGI™). Major diagnostic criteria included disorientation to time, place, and person, asterixis, lethargy, and coma. Minimum HEGI requirements for OHE diagnosis included: (1) disorientation, or (2) presence of both lethargy and asterixis, or (3) coma. Inter- and intra-rater HEGI reproducibility were 97 % and 98 %, respectively. When applied to a phase II clinical trial population of 178 patients with 388 OHE episodes, HEGI demonstrated excellent concordance with investigator judgement. Additionally, a multi-stage study was conducted to develop a daily CG e-diary, based on OHE manifestations recognizable by CG including speech difficulties, unusual behavior, forgetfulness, confusion, disorientation and level of consciousness. The e-diary was designed for use on smart phone, laptop or desktop, utilized branching logic and skip patterns, incorporated automatic daily completion reminders and real time alerts to clinical sites to facilitate daily standardized CG input and was found to be user friendly and understandable. The HEGI and e-diary, which were developed using methodology accepted by regulatory authorities, are designed to facilitate the design and interpretation of clinical trials for OHE and improve outcomes for OHE patients in clinical practice.

KW - Altered mental status

KW - Chronic liver disease

KW - Cirrhosis

KW - Clinical trial

KW - Liver failure

UR - http://www.scopus.com/inward/record.url?scp=84973667713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973667713&partnerID=8YFLogxK

U2 - 10.1007/s11011-016-9851-9

DO - 10.1007/s11011-016-9851-9

M3 - Article

C2 - 27278222

AN - SCOPUS:84973667713

SP - 1

EP - 13

JO - Metabolic Brain Disease

JF - Metabolic Brain Disease

SN - 0885-7490

ER -